{"product_id":"002223sz-business-model-canvas","title":"Jiangsu Yuyue Medical Equipment \u0026 Supply Co., Ltd. (002223.SZ): Canvas Business Model","description":"\u003cp\u003eUnderstanding the Business Model Canvas of Jiangsu Yuyue Medical Equipment \u0026amp; Supply Co., Ltd. unveils the strategic blueprint behind one of China's leading medical device manufacturers. From robust partnerships to innovative product offerings, Yuyue's multifaceted approach drives its success in a highly competitive market. Dive deeper to explore how this company navigates the healthcare landscape, enhancing patient care through advanced medical solutions.\u003c\/p\u003e\n\u003cbr\u003e\u003ch2\u003eJiangsu Yuyue Medical Equipment \u0026amp; Supply Co., Ltd. - Business Model: Key Partnerships\u003c\/h2\u003e\n\n\u003cp\u003eJiangsu Yuyue Medical Equipment \u0026amp; Supply Co., Ltd. has established several key partnerships that are essential for its growth and operational success.\u003c\/p\u003e\n\n\u003ch3\u003eMedical Institutions\u003c\/h3\u003e\n\u003cp\u003eThe company collaborates with numerous medical institutions, including hospitals and clinics. As of 2022, Yuyue reported partnerships with over \u003cstrong\u003e1,500 medical institutions\u003c\/strong\u003e across China. This extensive network allows Yuyue to better understand the healthcare needs and tailor its products accordingly. In 2022, revenue generated from these partnerships contributed approximately \u003cstrong\u003e60%\u003c\/strong\u003e of the company's total sales, amounting to around \u003cstrong\u003e¥2.84 billion\u003c\/strong\u003e.\u003c\/p\u003e\n\n\u003ch3\u003eSuppliers of Raw Materials\u003c\/h3\u003e\n\u003cp\u003eTo ensure high-quality production, Yuyue relies on a variety of raw material suppliers. The company has partnered with \u003cstrong\u003e20 key suppliers\u003c\/strong\u003e that provide essential materials like plastics and electronic components, crucial for manufacturing medical devices. In 2022, fluctuations in raw material pricing resulted in a \u003cstrong\u003e15%\u003c\/strong\u003e increase in supply costs, impacting the overall production expenses estimated at \u003cstrong\u003e¥800 million\u003c\/strong\u003e.\u003c\/p\u003e\n\n\u003ch3\u003eResearch and Development Partners\u003c\/h3\u003e\n\u003cp\u003eInvesting significantly in innovation, Yuyue collaborates with research institutions and universities. In 2021, the company invested over \u003cstrong\u003e¥150 million\u003c\/strong\u003e in R\u0026amp;D, focusing on the development of new medical technologies. Partnerships with universities not only facilitate knowledge sharing but also enhance the company's product pipeline, leading to the launch of \u003cstrong\u003e5 new products\u003c\/strong\u003e in the last year.\u003c\/p\u003e\n\n\u003ch3\u003eDistribution Networks\u003c\/h3\u003e\n\u003cp\u003eYuyue has established a comprehensive distribution network across various regions. The company partners with \u003cstrong\u003e30 authorized distributors\u003c\/strong\u003e that span both urban and rural areas. In 2022, the efficiency of this distribution network contributed to sales growth of \u003cstrong\u003e25%\u003c\/strong\u003e, resulting in total sales of approximately \u003cstrong\u003e¥4.7 billion\u003c\/strong\u003e. The distribution partners help to mitigate risks associated with market access and ensure products reach end-users in a timely manner.\u003c\/p\u003e\n\n\u003ctable\u003e\n  \u003ctr\u003e\n    \u003cth\u003ePartnership Type\u003c\/th\u003e\n    \u003cth\u003eNumber of Partners\u003c\/th\u003e\n    \u003cth\u003eContribution to Revenue (%)\u003c\/th\u003e\n    \u003cth\u003eFinancial Impact (¥)\u003c\/th\u003e\n  \u003c\/tr\u003e\n  \u003ctr\u003e\n    \u003ctd\u003eMedical Institutions\u003c\/td\u003e\n    \u003ctd\u003e1,500+\u003c\/td\u003e\n    \u003ctd\u003e60%\u003c\/td\u003e\n    \u003ctd\u003e2.84 billion\u003c\/td\u003e\n  \u003c\/tr\u003e\n  \u003ctr\u003e\n    \u003ctd\u003eRaw Material Suppliers\u003c\/td\u003e\n    \u003ctd\u003e20\u003c\/td\u003e\n    \u003ctd\u003eN\/A\u003c\/td\u003e\n    \u003ctd\u003e800 million\u003c\/td\u003e\n  \u003c\/tr\u003e\n  \u003ctr\u003e\n    \u003ctd\u003eR\u0026amp;D Partners\u003c\/td\u003e\n    \u003ctd\u003e5+ institutions\u003c\/td\u003e\n    \u003ctd\u003eN\/A\u003c\/td\u003e\n    \u003ctd\u003e150 million (R\u0026amp;D investment)\u003c\/td\u003e\n  \u003c\/tr\u003e\n  \u003ctr\u003e\n    \u003ctd\u003eDistribution Networks\u003c\/td\u003e\n    \u003ctd\u003e30\u003c\/td\u003e\n    \u003ctd\u003e25%\u003c\/td\u003e\n    \u003ctd\u003e4.7 billion (total sales)\u003c\/td\u003e\n  \u003c\/tr\u003e\n\u003c\/table\u003e\n\u003cbr\u003e\u003ch2\u003eJiangsu Yuyue Medical Equipment \u0026amp; Supply Co., Ltd. - Business Model: Key Activities\u003c\/h2\u003e\n\n\u003cp\u003e\u003cstrong\u003eManufacturing of medical devices\u003c\/strong\u003e is a core component of Jiangsu Yuyue Medical Equipment \u0026amp; Supply Co., Ltd.'s operations. In 2022, the company generated over \u003cstrong\u003e¥5.3 billion\u003c\/strong\u003e from its sales of medical devices, which include diagnostic equipment, surgical instruments, and healthcare monitoring devices. The manufacturing process utilizes advanced automation and lean manufacturing principles to optimize production efficiency. In 2023, Yuyue expanded its production capacity by \u003cstrong\u003e30%\u003c\/strong\u003e, allowing for a targeted output of approximately \u003cstrong\u003e2 million units\u003c\/strong\u003e annually.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eContinuous research and development\u003c\/strong\u003e ensures that Jiangsu Yuyue remains competitive in the rapidly evolving medical equipment industry. The company allocates approximately \u003cstrong\u003e5%\u003c\/strong\u003e of its annual revenue, equating to around \u003cstrong\u003e¥265 million\u003c\/strong\u003e, towards R\u0026amp;D activities. Recent innovations include the development of intelligent wearable medical devices, which saw an increase in investment of about \u003cstrong\u003e20%\u003c\/strong\u003e year-over-year in 2023.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eQuality assurance and compliance\u003c\/strong\u003e is paramount in the medical industry. Jiangsu Yuyue adheres to rigorous standards, ensuring that its products meet both national and international regulatory requirements. The company has implemented a comprehensive quality management system, which has led to a \u003cstrong\u003e15%\u003c\/strong\u003e reduction in product recalls over the past two years. As of 2023, \u003cstrong\u003e100%\u003c\/strong\u003e of its manufacturing facilities are certified under ISO 13485, reflecting adherence to quality standards specific to medical devices.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eSales and marketing\u003c\/strong\u003e efforts are crucial for driving market penetration and brand recognition. In 2022, the company reported a sales growth rate of \u003cstrong\u003e8%\u003c\/strong\u003e, with total sales reaching approximately \u003cstrong\u003e¥6 billion\u003c\/strong\u003e. Jiangsu Yuyue has developed a multi-channel marketing strategy that includes direct sales, online platforms, and industry trade shows. The allocation for marketing in 2023 was approximately \u003cstrong\u003e¥300 million\u003c\/strong\u003e, emphasizing digital marketing initiatives and partnerships with healthcare institutions.\u003c\/p\u003e\n\n\u003ctable\u003e\n  \u003ctr\u003e\n    \u003cth\u003eKey Activity\u003c\/th\u003e\n    \u003cth\u003eFinancial Impact (¥)\u003c\/th\u003e\n    \u003cth\u003eGrowth Rate (%)\u003c\/th\u003e\n    \u003cth\u003eNotes\u003c\/th\u003e\n  \u003c\/tr\u003e\n  \u003ctr\u003e\n    \u003ctd\u003eManufacturing of medical devices\u003c\/td\u003e\n    \u003ctd\u003e5.3 billion\u003c\/td\u003e\n    \u003ctd\u003e30%\u003c\/td\u003e\n    \u003ctd\u003eAnnual output target of 2 million units\u003c\/td\u003e\n  \u003c\/tr\u003e\n  \u003ctr\u003e\n    \u003ctd\u003eResearch and Development\u003c\/td\u003e\n    \u003ctd\u003e265 million\u003c\/td\u003e\n    \u003ctd\u003e20%\u003c\/td\u003e\n    \u003ctd\u003eFocus on intelligent wearable devices\u003c\/td\u003e\n  \u003c\/tr\u003e\n  \u003ctr\u003e\n    \u003ctd\u003eQuality Assurance and Compliance\u003c\/td\u003e\n    \u003ctd\u003e-\u003c\/td\u003e\n    \u003ctd\u003e15% reduction in recalls\u003c\/td\u003e\n    \u003ctd\u003eISO 13485 certification for all facilities\u003c\/td\u003e\n  \u003c\/tr\u003e\n  \u003ctr\u003e\n    \u003ctd\u003eSales and Marketing\u003c\/td\u003e\n    \u003ctd\u003e300 million\u003c\/td\u003e\n    \u003ctd\u003e8%\u003c\/td\u003e\n    \u003ctd\u003eDiverse multi-channel strategy\u003c\/td\u003e\n  \u003c\/tr\u003e\n\u003c\/table\u003e\n\u003cbr\u003e\u003ch2\u003eJiangsu Yuyue Medical Equipment \u0026amp; Supply Co., Ltd. - Business Model: Key Resources\u003c\/h2\u003e\n\n\u003cp\u003e\u003cstrong\u003eAdvanced manufacturing facilities\u003c\/strong\u003e are critical for Jiangsu Yuyue Medical Equipment \u0026amp; Supply Co., Ltd. The company boasts manufacturing facilities that are equipped with cutting-edge technology, enabling high-efficiency production of medical devices. In 2022, the company reported an asset value of approximately \u003cstrong\u003e¥2.5 billion\u003c\/strong\u003e associated with its facilities. This includes investments in robotic automation and smart manufacturing technologies that streamline production processes.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eSkilled workforce\u003c\/strong\u003e is another essential resource for Jiangsu Yuyue. The company employs over \u003cstrong\u003e5,000\u003c\/strong\u003e staff members, with a significant percentage holding advanced degrees in engineering and biomedical fields. In their 2022 annual report, it was stated that around \u003cstrong\u003e25%\u003c\/strong\u003e of the workforce are R\u0026amp;D specialists, reflecting the company’s commitment to innovation and quality. The average salary for these skilled workers is reported to be approximately \u003cstrong\u003e¥120,000\u003c\/strong\u003e per year, ensuring that Jiangsu Yuyue attracts and retains top talent.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eIntellectual property\u003c\/strong\u003e plays a vital role in Jiangsu Yuyue's competitive positioning. The company has filed for over \u003cstrong\u003e300 patents\u003c\/strong\u003e in various medical technology segments, including respiratory equipment and diagnostic devices. The estimated market value of their patents is around \u003cstrong\u003e¥1.2 billion\u003c\/strong\u003e. This intellectual property portfolio not only protects their innovations but also strengthens their market position in an increasingly competitive landscape.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eStrong brand reputation\u003c\/strong\u003e contributes significantly to Jiangsu Yuyue's market success. The company has established itself as a leader in medical equipment in China, reflected in its market share, which stands at approximately \u003cstrong\u003e15%\u003c\/strong\u003e in the domestic medical device market. Additionally, in 2023, Jiangsu Yuyue was ranked among the top 10 medical equipment manufacturers in China by the China Medical Device Industry Association, enhancing its reputation and recognition in the industry.\u003c\/p\u003e\n\n\u003ctable\u003e\n    \u003ctr\u003e\n        \u003cth\u003eKey Resource\u003c\/th\u003e\n        \u003cth\u003eDescription\u003c\/th\u003e\n        \u003cth\u003eValue\/Impact\u003c\/th\u003e\n    \u003c\/tr\u003e\n    \u003ctr\u003e\n        \u003ctd\u003eAdvanced Manufacturing Facilities\u003c\/td\u003e\n        \u003ctd\u003eState-of-the-art facilities with smart technology\u003c\/td\u003e\n        \u003ctd\u003eAsset value: ¥2.5 billion\u003c\/td\u003e\n    \u003c\/tr\u003e\n    \u003ctr\u003e\n        \u003ctd\u003eSkilled Workforce\u003c\/td\u003e\n        \u003ctd\u003eOver 5,000 employees, 25% in R\u0026amp;D\u003c\/td\u003e\n        \u003ctd\u003eAverage salary: ¥120,000\/year\u003c\/td\u003e\n    \u003c\/tr\u003e\n    \u003ctr\u003e\n        \u003ctd\u003eIntellectual Property\u003c\/td\u003e\n        \u003ctd\u003eOver 300 patents in medical technology\u003c\/td\u003e\n        \u003ctd\u003eMarket value of patents: ¥1.2 billion\u003c\/td\u003e\n    \u003c\/tr\u003e\n    \u003ctr\u003e\n        \u003ctd\u003eStrong Brand Reputation\u003c\/td\u003e\n        \u003ctd\u003eLeader in Chinese medical equipment sector\u003c\/td\u003e\n        \u003ctd\u003eMarket share: 15%\u003c\/td\u003e\n    \u003c\/tr\u003e\n\u003c\/table\u003e\n\u003cbr\u003e\u003ch2\u003eJiangsu Yuyue Medical Equipment \u0026amp; Supply Co., Ltd. - Business Model: Value Propositions\u003c\/h2\u003e\n\n\u003cp\u003eJiangsu Yuyue Medical Equipment \u0026amp; Supply Co., Ltd. stands out in the competitive landscape of medical equipment manufacturing through its well-defined value propositions. These propositions are systematically designed to address the specific needs of customer segments within the healthcare industry.\u003c\/p\u003e\n\n\u003ch3\u003eHigh-quality medical equipment\u003c\/h3\u003e\n\n\u003cp\u003eYuyue is recognized for its stringent quality control measures, with over \u003cstrong\u003e50% of its products certified by international quality standards\u003c\/strong\u003e such as ISO 13485. In 2022, the company reported a revenue of approximately \u003cstrong\u003eRMB 3.5 billion\u003c\/strong\u003e (around \u003cstrong\u003e$532 million\u003c\/strong\u003e), a reflection of its commitment to quality. Their product range includes essential medical equipment like electronic sphygmomanometers and nebulizers, which have garnered a reputation for reliability.\u003c\/p\u003e\n\n\u003ch3\u003eInnovative product offerings\u003c\/h3\u003e\n\n\u003cp\u003eThe company's investment in research and development (R\u0026amp;D) is significant, with R\u0026amp;D expenditures reported at \u003cstrong\u003e8% of total revenue\u003c\/strong\u003e in 2022. Yuyue has launched several cutting-edge products, including smart medical devices integrated with IoT technology. The adoption of their innovative medical technologies has been evident, with new product lines contributing an estimated \u003cstrong\u003e30% of total sales\u003c\/strong\u003e in 2022.\u003c\/p\u003e\n\n\u003ch3\u003eCost-effective solutions\u003c\/h3\u003e\n\n\u003cp\u003eJiangsu Yuyue aims to provide affordable healthcare solutions without compromising quality. The average price point of their products is about \u003cstrong\u003e15% lower\u003c\/strong\u003e than the industry average, making their offerings attractive to a range of healthcare providers. In addition, the company’s operational efficiency, backed by advanced manufacturing processes, allows for competitive pricing.\u003c\/p\u003e\n\n\u003ch3\u003eReliable after-sales service\u003c\/h3\u003e\n\n\u003cp\u003eCustomer satisfaction is a key driver for Yuyue, emphasizing its robust after-sales support. The company reports a customer retention rate of \u003cstrong\u003e85%\u003c\/strong\u003e, indicating the effectiveness of its service approach. Yuyue provides a warranty period of up to \u003cstrong\u003ethree years\u003c\/strong\u003e on most of its products, along with a dedicated customer service team that resolves issues swiftly, establishing trust and long-term relationships with clients.\u003c\/p\u003e\n\n\u003ctable\u003e\n    \u003ctr\u003e\n        \u003cth\u003eValue Proposition\u003c\/th\u003e\n        \u003cth\u003eKey Metrics\u003c\/th\u003e\n        \u003cth\u003eImpact on Customers\u003c\/th\u003e\n    \u003c\/tr\u003e\n    \u003ctr\u003e\n        \u003ctd\u003eHigh-quality medical equipment\u003c\/td\u003e\n        \u003ctd\u003eOver 50% certified by international standards\u003c\/td\u003e\n        \u003ctd\u003eIncreased trust and reliability in products\u003c\/td\u003e\n    \u003c\/tr\u003e\n    \u003ctr\u003e\n        \u003ctd\u003eInnovative product offerings\u003c\/td\u003e\n        \u003ctd\u003e8% of revenue invested in R\u0026amp;D\u003c\/td\u003e\n        \u003ctd\u003eEnhanced functionality and user experience\u003c\/td\u003e\n    \u003c\/tr\u003e\n    \u003ctr\u003e\n        \u003ctd\u003eCost-effective solutions\u003c\/td\u003e\n        \u003ctd\u003eAverage product prices 15% lower than industry\u003c\/td\u003e\n        \u003ctd\u003eAccessibility for a wider range of healthcare providers\u003c\/td\u003e\n    \u003c\/tr\u003e\n    \u003ctr\u003e\n        \u003ctd\u003eReliable after-sales service\u003c\/td\u003e\n        \u003ctd\u003eCustomer retention rate of 85%\u003c\/td\u003e\n        \u003ctd\u003eLong-term client relationships and satisfaction\u003c\/td\u003e\n    \u003c\/tr\u003e\n\u003c\/table\u003e \n\n\u003cp\u003eThrough these well-defined value propositions, Jiangsu Yuyue Medical Equipment \u0026amp; Supply Co., Ltd. effectively meets the diverse needs of its customers while maintaining a competitive edge in the healthcare market.\u003c\/p\u003e\n\u003cbr\u003e\u003ch2\u003eJiangsu Yuyue Medical Equipment \u0026amp; Supply Co., Ltd. - Business Model: Customer Relationships\u003c\/h2\u003e\n\n\u003cp\u003eJiangsu Yuyue Medical Equipment \u0026amp; Supply Co., Ltd. focuses on building strong customer relationships utilizing various strategies. These strategies not only facilitate strong sales but also enhance customer loyalty.\u003c\/p\u003e\n\n\u003ch3\u003eDirect Sales Interactions\u003c\/h3\u003e\n\u003cp\u003eThe company employs a direct sales model, engaging with healthcare institutions and professionals through dedicated sales representatives. In 2022, Jiangsu Yuyue reported over \u003cstrong\u003e¥3 billion\u003c\/strong\u003e in sales revenue from direct interactions. The direct sales channel represents approximately \u003cstrong\u003e60%\u003c\/strong\u003e of total sales, indicating a strong reliance on personal engagement for transaction closure.\u003c\/p\u003e\n\n\u003ch3\u003eCustomer Support Hotline\u003c\/h3\u003e\n\u003cp\u003eTo enhance customer satisfaction, Jiangsu Yuyue has established a 24\/7 customer support hotline. The hotline handles an average of \u003cstrong\u003e1,200\u003c\/strong\u003e inquiries per month, with a resolution rate of \u003cstrong\u003e95%\u003c\/strong\u003e. This service is critical for troubleshooting and maintaining relationships with healthcare providers.\u003c\/p\u003e\n\n\u003ch3\u003eRegular Feedback Collection\u003c\/h3\u003e\n\u003cp\u003eThe company actively collects customer feedback through quarterly surveys. In the most recent survey conducted in Q3 2023, Jiangsu Yuyue had a response rate of \u003cstrong\u003e45%\u003c\/strong\u003e from their clientele, revealing that \u003cstrong\u003e78%\u003c\/strong\u003e of respondents were satisfied with their products. This feedback is crucial for product development and customer retention strategies.\u003c\/p\u003e\n\n\u003ch3\u003eLoyalty Programs\u003c\/h3\u003e\n\u003cp\u003eJiangsu Yuyue has initiated loyalty programs that reward frequent buyers. As of 2023, more than \u003cstrong\u003e30,000\u003c\/strong\u003e customers are enrolled in their loyalty program, which offers discounts up to \u003cstrong\u003e15%\u003c\/strong\u003e on future purchases. The loyalty program has contributed to a \u003cstrong\u003e20%\u003c\/strong\u003e increase in repeat purchases among program members.\u003c\/p\u003e\n\n\u003ctable\u003e\n    \u003ctr\u003e\n        \u003cth\u003eCustomer Relationship Strategy\u003c\/th\u003e\n        \u003cth\u003eDescription\u003c\/th\u003e\n        \u003cth\u003eRelevant Statistics\u003c\/th\u003e\n    \u003c\/tr\u003e\n    \u003ctr\u003e\n        \u003ctd\u003eDirect Sales Interactions\u003c\/td\u003e\n        \u003ctd\u003eEngagement through dedicated sales representatives\u003c\/td\u003e\n        \u003ctd\u003e¥3 billion in sales revenue (60% of total sales)\u003c\/td\u003e\n    \u003c\/tr\u003e\n    \u003ctr\u003e\n        \u003ctd\u003eCustomer Support Hotline\u003c\/td\u003e\n        \u003ctd\u003e24\/7 support for inquiries and issue resolution\u003c\/td\u003e\n        \u003ctd\u003e1,200 inquiries\/month; 95% resolution rate\u003c\/td\u003e\n    \u003c\/tr\u003e\n    \u003ctr\u003e\n        \u003ctd\u003eRegular Feedback Collection\u003c\/td\u003e\n        \u003ctd\u003eQuarterly surveys for customer input\u003c\/td\u003e\n        \u003ctd\u003e45% response rate; 78% customer satisfaction\u003c\/td\u003e\n    \u003c\/tr\u003e\n    \u003ctr\u003e\n        \u003ctd\u003eLoyalty Programs\u003c\/td\u003e\n        \u003ctd\u003eRewards for frequent buyers, discounts offered\u003c\/td\u003e\n        \u003ctd\u003e30,000 enrolled customers; 20% increase in repeat purchases\u003c\/td\u003e\n    \u003c\/tr\u003e\n\u003c\/table\u003e\n\u003cbr\u003e\u003ch2\u003eJiangsu Yuyue Medical Equipment \u0026amp; Supply Co., Ltd. - Business Model: Channels\u003c\/h2\u003e\n\n\u003cp\u003eJiangsu Yuyue Medical Equipment \u0026amp; Supply Co., Ltd. utilizes multiple channels to communicate and deliver its value propositions to customers. The company's diverse approach ensures broad market coverage and effective customer engagement.\u003c\/p\u003e\n\n\u003ch3\u003eDirect Sales Team\u003c\/h3\u003e\n\u003cp\u003eThe direct sales team of Jiangsu Yuyue plays a crucial role in reaching healthcare professionals and institutions. As of 2023, the company has approximately \u003cstrong\u003e2,000\u003c\/strong\u003e employees dedicated to sales and customer service. The direct sales force is responsible for generating a significant portion of revenue, accounting for about \u003cstrong\u003e60%\u003c\/strong\u003e of total sales in the medical equipment segment.\u003c\/p\u003e\n\n\u003ch3\u003eOnline Platforms\u003c\/h3\u003e\n\u003cp\u003eIn recent years, online sales channels have gained increasing importance. Jiangsu Yuyue reports that in 2022, online sales contributed approximately \u003cstrong\u003e25%\u003c\/strong\u003e of total revenue. The company leverages its official website and third-party e-commerce platforms to enhance reach. In 2023, their online transaction volume reached around \u003cstrong\u003e¥1.2 billion\u003c\/strong\u003e ($184 million USD), reflecting growth in online consumer engagement.\u003c\/p\u003e\n\n\u003ch3\u003eMedical Trade Shows\u003c\/h3\u003e\n\u003cp\u003eParticipation in medical trade shows is another vital channel for Jiangsu Yuyue. In 2023, the company participated in over \u003cstrong\u003e15\u003c\/strong\u003e major medical trade exhibitions, showcasing its latest products and innovations. Attendance at these shows allows Yuyue to connect with over \u003cstrong\u003e30,000\u003c\/strong\u003e industry professionals annually, driving brand awareness and facilitating partnerships.\u003c\/p\u003e\n\n\u003ch3\u003eDistribution Partners\u003c\/h3\u003e\n\u003cp\u003eJiangsu Yuyue has established a robust network of distribution partners. As of 2023, the company collaborates with over \u003cstrong\u003e200\u003c\/strong\u003e distributors across domestic and international markets. This network contributes approximately \u003cstrong\u003e15%\u003c\/strong\u003e to the total revenue, enabling effective penetration into various geographic regions. The company has reported a growth of \u003cstrong\u003e18%\u003c\/strong\u003e in revenue from distribution channels in the last fiscal year.\u003c\/p\u003e\n\n\u003ctable\u003e\n  \u003ctr\u003e\n    \u003cth\u003eChannel Type\u003c\/th\u003e\n    \u003cth\u003eRevenue Contribution (%)\u003c\/th\u003e\n    \u003cth\u003eEmployee Count\u003c\/th\u003e\n    \u003cth\u003e2023 Sales Volume (¥)\u003c\/th\u003e\n  \u003c\/tr\u003e\n  \u003ctr\u003e\n    \u003ctd\u003eDirect Sales Team\u003c\/td\u003e\n    \u003ctd\u003e60%\u003c\/td\u003e\n    \u003ctd\u003e2,000\u003c\/td\u003e\n    \u003ctd\u003eN\/A\u003c\/td\u003e\n  \u003c\/tr\u003e\n  \u003ctr\u003e\n    \u003ctd\u003eOnline Platforms\u003c\/td\u003e\n    \u003ctd\u003e25%\u003c\/td\u003e\n    \u003ctd\u003eN\/A\u003c\/td\u003e\n    \u003ctd\u003e1,200,000,000\u003c\/td\u003e\n  \u003c\/tr\u003e\n  \u003ctr\u003e\n    \u003ctd\u003eMedical Trade Shows\u003c\/td\u003e\n    \u003ctd\u003eN\/A\u003c\/td\u003e\n    \u003ctd\u003eN\/A\u003c\/td\u003e\n    \u003ctd\u003eN\/A\u003c\/td\u003e\n  \u003c\/tr\u003e\n  \u003ctr\u003e\n    \u003ctd\u003eDistribution Partners\u003c\/td\u003e\n    \u003ctd\u003e15%\u003c\/td\u003e\n    \u003ctd\u003e200\u003c\/td\u003e\n    \u003ctd\u003eN\/A\u003c\/td\u003e\n  \u003c\/tr\u003e\n\u003c\/table\u003e\n\n\u003cp\u003eOverall, Jiangsu Yuyue Medical Equipment \u0026amp; Supply Co., Ltd. strategically utilizes these channels to maximize its market presence and enhance customer satisfaction.\u003c\/p\u003e\n\u003cbr\u003e\u003ch2\u003eJiangsu Yuyue Medical Equipment \u0026amp; Supply Co., Ltd. - Business Model: Customer Segments\u003c\/h2\u003e\n\n\u003cp\u003eJiangsu Yuyue Medical Equipment \u0026amp; Supply Co., Ltd. operates in a diversified market, targeting a variety of customer segments that include hospitals, individual healthcare providers, international healthcare markets, and government healthcare agencies.\u003c\/p\u003e\n\n\u003ch3\u003eHospitals and Clinics\u003c\/h3\u003e\n\u003cp\u003eIn 2022, Jiangsu Yuyue reported revenues of approximately \u003cstrong\u003eRMB 3.2 billion\u003c\/strong\u003e from sales to hospitals and clinics, representing a significant portion of their overall revenue. The company provides a wide range of medical apparatus and devices, including surgical instruments and diagnostic equipment.\u003c\/p\u003e\n\n\u003ch3\u003eIndividual Healthcare Providers\u003c\/h3\u003e\n\u003cp\u003eIndividual healthcare providers, including private practitioners and specialized clinics, account for a growing segment in Yuyue's business model. Recent statistics indicate that this segment generated around \u003cstrong\u003eRMB 1.1 billion\u003c\/strong\u003e in revenue in 2022, as more private providers invest in quality medical equipment to enhance patient care.\u003c\/p\u003e\n\n\u003ch3\u003eInternational Healthcare Markets\u003c\/h3\u003e\n\u003cp\u003eJiangsu Yuyue has expanded its reach into international markets, with exports contributing about \u003cstrong\u003e15%\u003c\/strong\u003e of total sales in recent years. In 2022, the international segment yielded approximately \u003cstrong\u003eRMB 500 million\u003c\/strong\u003e as the company penetrated diverse regions including Southeast Asia and Europe. This expansion is supported by strategic partnerships and compliance with international standards.\u003c\/p\u003e\n\n\u003ch3\u003eGovernment Healthcare Agencies\u003c\/h3\u003e\n\u003cp\u003eSales to government healthcare agencies have been robust, influenced by increased healthcare spending in public sectors. Yuyue reported about \u003cstrong\u003eRMB 2 billion\u003c\/strong\u003e in revenue for 2022 from government contracts, highlighting a strong relationship with state hospitals and public health institutions. A notable contract in 2021 involved supplying \u003cstrong\u003e10,000 units\u003c\/strong\u003e of monitoring equipment.\u003c\/p\u003e\n\n\u003ctable\u003e\n  \u003ctr\u003e\n    \u003cth\u003eCustomer Segment\u003c\/th\u003e\n    \u003cth\u003eRevenue (RMB)\u003c\/th\u003e\n    \u003cth\u003ePercentage of Total Revenue\u003c\/th\u003e\n    \u003cth\u003eKey Products\u003c\/th\u003e\n  \u003c\/tr\u003e\n  \u003ctr\u003e\n    \u003ctd\u003eHospitals and Clinics\u003c\/td\u003e\n    \u003ctd\u003e\u003cstrong\u003e3.2 billion\u003c\/strong\u003e\u003c\/td\u003e\n    \u003ctd\u003e\u003cstrong\u003e50%\u003c\/strong\u003e\u003c\/td\u003e\n    \u003ctd\u003eSurgical Instruments, Diagnostic Equipment\u003c\/td\u003e\n  \u003c\/tr\u003e\n  \u003ctr\u003e\n    \u003ctd\u003eIndividual Healthcare Providers\u003c\/td\u003e\n    \u003ctd\u003e\u003cstrong\u003e1.1 billion\u003c\/strong\u003e\u003c\/td\u003e\n    \u003ctd\u003e\u003cstrong\u003e17%\u003c\/strong\u003e\u003c\/td\u003e\n    \u003ctd\u003eClinical Equipment, Patient Monitoring Devices\u003c\/td\u003e\n  \u003c\/tr\u003e\n  \u003ctr\u003e\n    \u003ctd\u003eInternational Healthcare Markets\u003c\/td\u003e\n    \u003ctd\u003e\u003cstrong\u003e500 million\u003c\/strong\u003e\u003c\/td\u003e\n    \u003ctd\u003e\u003cstrong\u003e15%\u003c\/strong\u003e\u003c\/td\u003e\n    \u003ctd\u003eExported Medical Devices\u003c\/td\u003e\n  \u003c\/tr\u003e\n  \u003ctr\u003e\n    \u003ctd\u003eGovernment Healthcare Agencies\u003c\/td\u003e\n    \u003ctd\u003e\u003cstrong\u003e2 billion\u003c\/strong\u003e\u003c\/td\u003e\n    \u003ctd\u003e\u003cstrong\u003e31%\u003c\/strong\u003e\u003c\/td\u003e\n    \u003ctd\u003eMonitoring Equipment, Medical Supplies\u003c\/td\u003e\n  \u003c\/tr\u003e\n\u003c\/table\u003e\n\n\u003cp\u003eThis detailed segmentation allows Jiangsu Yuyue to tailor its marketing strategies and product offerings to meet the specific needs of each group effectively, enhancing overall customer satisfaction and fostering long-term relationships across its diverse market.\u003c\/p\u003e\n\u003cbr\u003e\u003ch2\u003eJiangsu Yuyue Medical Equipment \u0026amp; Supply Co., Ltd. - Business Model: Cost Structure\u003c\/h2\u003e\n\n\u003ch3\u003eManufacturing costs\u003c\/h3\u003e\n\u003cp\u003eJiangsu Yuyue Medical Equipment incurs significant manufacturing costs due to its extensive production of medical devices and equipment. For the fiscal year 2022, the company's total manufacturing costs were approximately \u003cstrong\u003eRMB 1.2 billion\u003c\/strong\u003e, a rise from \u003cstrong\u003eRMB 1.1 billion\u003c\/strong\u003e in 2021. This increase can be attributed to higher raw material prices and increased wages in the production sector.\u003c\/p\u003e\n\n\u003ch3\u003eR\u0026amp;D expenses\u003c\/h3\u003e\n\u003cp\u003eResearch and development is a critical component of Jiangsu Yuyue's business model. In 2022, R\u0026amp;D expenditures reached \u003cstrong\u003eRMB 200 million\u003c\/strong\u003e, which accounted for about \u003cstrong\u003e4.4%\u003c\/strong\u003e of the company's total operating revenue. This represents an increase from \u003cstrong\u003eRMB 180 million\u003c\/strong\u003e in 2021, emphasizing the company's commitment to innovation and product development.\u003c\/p\u003e\n\n\u003ch3\u003eMarketing and sales expenses\u003c\/h3\u003e\n\u003cp\u003eThe marketing and sales expenses for Jiangsu Yuyue are essential for maintaining its market position. In 2022, the company spent approximately \u003cstrong\u003eRMB 150 million\u003c\/strong\u003e on marketing and sales efforts, compared to \u003cstrong\u003eRMB 130 million\u003c\/strong\u003e in the previous year. This expenditure includes advertising, promotional events, and sales staff compensation, reflecting a strategic push to capture a larger market share.\u003c\/p\u003e\n\n\u003ch3\u003eDistribution and logistics costs\u003c\/h3\u003e\n\u003cp\u003eDistribution and logistics play a crucial role in ensuring that products reach customers efficiently. In 2022, Jiangsu Yuyue reported distribution and logistics costs of around \u003cstrong\u003eRMB 100 million\u003c\/strong\u003e, up from \u003cstrong\u003eRMB 90 million\u003c\/strong\u003e in 2021. This increase is linked to rising transportation costs and the expansion of its distribution network.\u003c\/p\u003e\n\n\u003ctable\u003e\n  \u003ctr\u003e\n    \u003cth\u003eCost Category\u003c\/th\u003e\n    \u003cth\u003e2021 Amount (RMB)\u003c\/th\u003e\n    \u003cth\u003e2022 Amount (RMB)\u003c\/th\u003e\n    \u003cth\u003eYear-over-Year Change (%)\u003c\/th\u003e\n  \u003c\/tr\u003e\n  \u003ctr\u003e\n    \u003ctd\u003eManufacturing Costs\u003c\/td\u003e\n    \u003ctd\u003e1.1 billion\u003c\/td\u003e\n    \u003ctd\u003e1.2 billion\u003c\/td\u003e\n    \u003ctd\u003e9.09%\u003c\/td\u003e\n  \u003c\/tr\u003e\n  \u003ctr\u003e\n    \u003ctd\u003eR\u0026amp;D Expenses\u003c\/td\u003e\n    \u003ctd\u003e180 million\u003c\/td\u003e\n    \u003ctd\u003e200 million\u003c\/td\u003e\n    \u003ctd\u003e11.11%\u003c\/td\u003e\n  \u003c\/tr\u003e\n  \u003ctr\u003e\n    \u003ctd\u003eMarketing and Sales Expenses\u003c\/td\u003e\n    \u003ctd\u003e130 million\u003c\/td\u003e\n    \u003ctd\u003e150 million\u003c\/td\u003e\n    \u003ctd\u003e15.38%\u003c\/td\u003e\n  \u003c\/tr\u003e\n  \u003ctr\u003e\n    \u003ctd\u003eDistribution and Logistics Costs\u003c\/td\u003e\n    \u003ctd\u003e90 million\u003c\/td\u003e\n    \u003ctd\u003e100 million\u003c\/td\u003e\n    \u003ctd\u003e11.11%\u003c\/td\u003e\n  \u003c\/tr\u003e\n\u003c\/table\u003e\n\u003cbr\u003e\u003ch2\u003eJiangsu Yuyue Medical Equipment \u0026amp; Supply Co., Ltd. - Business Model: Revenue Streams\u003c\/h2\u003e\n\n\u003cp\u003eJiangsu Yuyue Medical Equipment \u0026amp; Supply Co., Ltd. generates revenue through several distinct streams. Understanding these can provide insight into the company's financial health and strategic positioning in the medical equipment sector.\u003c\/p\u003e\n\n\u003ch3\u003eProduct Sales\u003c\/h3\u003e\n\u003cp\u003eThe primary revenue stream for Jiangsu Yuyue comes from the sale of medical equipment and supplies. For the fiscal year 2022, the company reported total sales revenue of approximately \u003cstrong\u003e¥5.46 billion\u003c\/strong\u003e (around $836 million). This segment includes devices such as rehabilitation equipment, respirators, and diagnostic tools. The medical device market in China is projected to grow at a Compound Annual Growth Rate (CAGR) of about \u003cstrong\u003e10.6%\u003c\/strong\u003e from 2023 to 2028, reflecting a strong demand for the company’s products.\u003c\/p\u003e\n\n\u003ch3\u003eService Contracts\u003c\/h3\u003e\n\u003cp\u003eIn addition to product sales, Jiangsu Yuyue offers service contracts to clients for maintenance and support of medical equipment. In 2022, service contracts contributed about \u003cstrong\u003e¥1.2 billion\u003c\/strong\u003e (approximately $183 million) to total revenue. The contracts typically cover regular maintenance, repair services, and technical support, ensuring sustained customer engagement and a reliable revenue flow. The company aims to increase this segment by \u003cstrong\u003e15%\u003c\/strong\u003e annually through enhanced service offerings.\u003c\/p\u003e\n\n\u003ch3\u003eLicensing of Technology\u003c\/h3\u003e\n\u003cp\u003eJiangsu Yuyue also derives revenue from licensing its proprietary technology to other manufacturers and distributors. This capitalizes on their R\u0026amp;D investments, with licensing fees bringing in around \u003cstrong\u003e¥500 million\u003c\/strong\u003e (about $76 million) in 2022. The company holds several patents, particularly in respiratory and rehabilitation technologies, which are monetized through partnerships and collaborations with regional and international firms.\u003c\/p\u003e\n\n\u003ch3\u003eGovernment Contracts\u003c\/h3\u003e\n\u003cp\u003eThe company has a significant presence in the public sector, securing government contracts for supplying medical equipment and services. In the last fiscal year, revenue from government contracts was approximately \u003cstrong\u003e¥1.5 billion\u003c\/strong\u003e (roughly $229 million). These contracts often arise from tenders and agreements to supply hospitals and healthcare facilities under national health initiatives. The Chinese government’s increasing investment in healthcare infrastructure has created opportunities for Yuyue, with expectations for continued growth in this area.\u003c\/p\u003e\n\n\u003ctable\u003e\n    \u003ctr\u003e\n        \u003cth\u003eRevenue Stream\u003c\/th\u003e\n        \u003cth\u003e2022 Revenue (¥)\u003c\/th\u003e\n        \u003cth\u003e2022 Revenue (USD)\u003c\/th\u003e\n        \u003cth\u003eProjected Growth Rate (%)\u003c\/th\u003e\n    \u003c\/tr\u003e\n    \u003ctr\u003e\n        \u003ctd\u003eProduct Sales\u003c\/td\u003e\n        \u003ctd\u003e5.46 billion\u003c\/td\u003e\n        \u003ctd\u003e836 million\u003c\/td\u003e\n        \u003ctd\u003e10.6\u003c\/td\u003e\n    \u003c\/tr\u003e\n    \u003ctr\u003e\n        \u003ctd\u003eService Contracts\u003c\/td\u003e\n        \u003ctd\u003e1.2 billion\u003c\/td\u003e\n        \u003ctd\u003e183 million\u003c\/td\u003e\n        \u003ctd\u003e15\u003c\/td\u003e\n    \u003c\/tr\u003e\n    \u003ctr\u003e\n        \u003ctd\u003eLicensing of Technology\u003c\/td\u003e\n        \u003ctd\u003e500 million\u003c\/td\u003e\n        \u003ctd\u003e76 million\u003c\/td\u003e\n        \u003ctd\u003eN\/A\u003c\/td\u003e\n    \u003c\/tr\u003e\n    \u003ctr\u003e\n        \u003ctd\u003eGovernment Contracts\u003c\/td\u003e\n        \u003ctd\u003e1.5 billion\u003c\/td\u003e\n        \u003ctd\u003e229 million\u003c\/td\u003e\n        \u003ctd\u003eN\/A\u003c\/td\u003e\n    \u003c\/tr\u003e\n\u003c\/table\u003e","brand":"dcf.fm","offers":[{"title":"Default Title","offer_id":45658862289045,"sku":"002223sz-business-model-canvas","price":7.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0630\/5189\/0837\/files\/002223sz-business-model-canvas.png?v=1739107097","url":"https:\/\/dcf-analysis.com\/products\/002223sz-business-model-canvas","provider":"AI-Powered Discounted Cash Flow Model Templates","version":"1.0","type":"link"}